(Q40090989)

17 September 2017

title

Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo (English)

1 reference

17 September 2017

1 reference

8

Katherine Cianflone

1 reference

17 September 2017

Wei Cui

1

1 reference

17 September 2017

Sabina Paglialunga

2

1 reference

17 September 2017

David Kalant

3

1 reference

17 September 2017

Huiling Lu

4

1 reference

17 September 2017

Christian Roy

5

1 reference

17 September 2017

Mathieu Laplante

6

1 reference

17 September 2017

Yves Deshaies

7

1 reference

17 September 2017

publication date

21 August 2007

1 reference

American Journal of Physiology - Endocrinology and Metabolism

17 September 2017

published in

1 reference

17 September 2017

volume

293

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

E1482-91

1 reference

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Lipid metabolism, exercise and insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Physiological parameter values for physiologically based pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Acylation stimulating protein and triacylglycerol synthesis: potential drug targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Critical review of acylation-stimulating protein physiology in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Is visceral obesity the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Characterisation of G-protein-coupled receptors by antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

C5L2 is a functional receptor for acylation-stimulating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Targeting the signaling pathway of acylation stimulating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Anthropometry and breast cancer risk in Nigerian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Lipoprotein lipase activity in muscle tissue influenced by fatness, fat distribution and insulin in obese females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Increased C5a receptor expression in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

AMP-activated protein kinase--the fat controller of the energy railroad

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Increased levels of acylation-stimulating protein in interleukin-6-deficient (IL-6(-/-)) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2006

10.1152/AJPENDO.00565.2006

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference